ArticleCancer discovery2012
Metabolomics strategy reveals subpopulation of liposarcomas sensitive to gemcitabine treatment.
Daniel Braas et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this papertrialcites it